Brain scans and a painkiller may unlock Depression's secrets

NCT ID NCT04276259

Completed Knowledge-focused Sponsor: Marta Peciña, MD PhD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This completed study looked at how the brain processes reward signals to improve mood in people with depression. Researchers used brain scans, a mild magnetic stimulation technique (TMS), and a single injection of buprenorphine (a painkiller) to see how these affect brain activity. The goal was to understand the brain mechanisms behind mood improvement, not to test a new treatment. 120 adults with depressive symptoms took part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: buprenorphine
What this could lead to: If successful, this could reveal how the brain's reward system influences mood, pointing toward new ways to treat depression.
What could go wrong: This is a small, early-stage study focused on brain mechanisms, not a treatment trial. Results may not lead to a direct therapy or apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION MAJOR DEPRESSIVE DISORDER

Contacts and locations

Locations

Bellefield Tower

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.